Search results
US opens COVID vaccine to little kids, shots begin next week
AOL· 5 days agoThe U.S. on Saturday opened COVID-19 vaccines to infants, toddlers and preschoolers. The shots will...
Moderna Breaks Out For The First Time In A Year After Covid Shot Wallops Sales Views
Investor's Business Daily· 3 days agoBut it can be serious or deadly in babies and older adults. The FDA is due to make its decision on...
A better COVID treatment for the immunocompromised? Researchers create a non-toxic potential...
Medical Xpress· 5 days agoPeople who are infected with SARS-CoV-2, the virus that causes COVID-19, currently have two options ...
FDA finalizes lab test regulations with more flexibility
Politico· 5 days agoCHIKUNGUNYA VACCINE SUBMISSION — Danish vaccine maker Bavarian...Bavarian Nordic has started submitting data to the FDA for approval ...
GSK Beats Q1 Earnings & Sales Estimates, Ups 2024 Guidance
Zacks via Yahoo Finance· 4 days agoGSK's revenues benefit from strong growth across the Specialty Medicines and Vaccines segments. The...
Peter Marks
Time Magazine· 3 days agoIn 2023, the U.S. Food and Drug Administration (FDA) brought a number of never-before-seen treatments to market, approving the first gene therapies using...
AP source: J&J doses to be released, but many will be tossed
AOL· 4 days agoU.S. regulators are allowing for the release of 10 million doses of Johnson & Johnson's COVID-19 ...
Health Freedom Prevails Against the CDC and NIH
Mercola· 5 hours agoIn the video above, Del Bigtree, founder of “The Highwire” and the Informed Consent Action Network (icandecide.org), shares some of the recent lawsuits ICAN has won against the National Institutes ...
Moderna Inc (MRNA) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges with ...
GuruFocus.com via Yahoo Finance· 2 days agoThe cost of sales represented...you discuss your strategy for pursuing contracts for the RSV vaccine given 2 approved vaccine sort of ...
Biotech’s bind over China bill
Politico· 2 days agoBULLISH ON RSV SHOT — Moderna executives signaled confidence Thursday that the drugmaker’s RSV vaccine can compete with shots already on the market if the FDA< ...
